Extended Reality Behavioral Activation: An Intervention for Major Depressive Disorder

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The primary aims of this study are to assess the feasibility, acceptability, and tolerability of using an immersive extended reality (XR) headset to engage in behavioral activation (BA) for individuals diagnosed with major depressive disorder (MDD). The secondary aim of this study is to explore the efficacy of using XR to enhance BA therapy in a clinical MDD population.
Epistemonikos ID: 4bb4bef59e13fa1595a784d1acefe86e7c5aac1b
First added on: May 13, 2024